These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

739 related items for PubMed ID: 21149605

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
    van der Vlist M, de Witte L, de Vries RD, Litjens M, de Jong MA, Fluitsma D, de Swart RL, Geijtenbeek TB.
    Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
    [Abstract] [Full Text] [Related]

  • 24. A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.
    Kakimi K, Isobe M, Uenaka A, Wada H, Sato E, Doki Y, Nakajima J, Seto Y, Yamatsuji T, Naomoto Y, Shiraishi K, Takigawa N, Kiura K, Tsuji K, Iwatsuki K, Oka M, Pan L, Hoffman EW, Old LJ, Nakayama E.
    Int J Cancer; 2011 Dec 15; 129(12):2836-46. PubMed ID: 21448901
    [Abstract] [Full Text] [Related]

  • 25. Identification of a naturally processed NY-ESO-1 peptide recognized by CD8+ T cells in the context of HLA-B51.
    Jäger E, Karbach J, Gnjatic S, Jäger D, Maeurer M, Atmaca A, Arand M, Skipper J, Stockert E, Chen YT, Old LJ, Knuth A.
    Cancer Immun; 2002 Sep 19; 2():12. PubMed ID: 12747757
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Survey of naturally occurring CD4+ T cell responses against NY-ESO-1 in cancer patients: correlation with antibody responses.
    Gnjatic S, Atanackovic D, Jäger E, Matsuo M, Selvakumar A, Altorki NK, Maki RG, Dupont B, Ritter G, Chen YT, Knuth A, Old LJ.
    Proc Natl Acad Sci U S A; 2003 Jul 22; 100(15):8862-7. PubMed ID: 12853579
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Induction of CD8 T-cell responses restricted to multiple HLA class I alleles in a cancer patient by immunization with a 20-mer NY-ESO-1f (NY-ESO-1 91-110) peptide.
    Eikawa S, Kakimi K, Isobe M, Kuzushima K, Luescher I, Ohue Y, Ikeuchi K, Uenaka A, Nishikawa H, Udono H, Oka M, Nakayama E.
    Int J Cancer; 2013 Jan 15; 132(2):345-54. PubMed ID: 22729530
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma.
    Pavlick A, Blazquez AB, Meseck M, Lattanzi M, Ott PA, Marron TU, Holman RM, Mandeli J, Salazar AM, McClain CB, Gimenez G, Balan S, Gnjatic S, Sabado RL, Bhardwaj N.
    Cancer Immunol Res; 2020 Jan 15; 8(1):70-80. PubMed ID: 31699709
    [Abstract] [Full Text] [Related]

  • 36. Identification of CD4+ T cell epitopes from NY-ESO-1 presented by HLA-DR molecules.
    Zeng G, Touloukian CE, Wang X, Restifo NP, Rosenberg SA, Wang RF.
    J Immunol; 2000 Jul 15; 165(2):1153-9. PubMed ID: 10878395
    [Abstract] [Full Text] [Related]

  • 37. Dendritic cell surface calreticulin is a receptor for NY-ESO-1: direct interactions between tumor-associated antigen and the innate immune system.
    Zeng G, Aldridge ME, Tian X, Seiler D, Zhang X, Jin Y, Rao J, Li W, Chen D, Langford MP, Duggan C, Belldegrun AS, Dubinett SM.
    J Immunol; 2006 Sep 15; 177(6):3582-9. PubMed ID: 16951317
    [Abstract] [Full Text] [Related]

  • 38. Epitope hierarchy of spontaneous CD4+ T cell responses to LAGE-1.
    Kudela P, Sun Z, Fourcade J, Janjic B, Kirkwood JM, Maillere B, Zarour HM.
    J Immunol; 2011 Jan 01; 186(1):312-22. PubMed ID: 21131422
    [Abstract] [Full Text] [Related]

  • 39. Fucoidin enhances dendritic cell-mediated T-cell cytotoxicity against NY-ESO-1 expressing human cancer cells.
    Hu Y, Cheng SC, Chan KT, Ke Y, Xue B, Sin FW, Zeng C, Xie Y.
    Biochem Biophys Res Commun; 2010 Feb 12; 392(3):329-34. PubMed ID: 20067767
    [Abstract] [Full Text] [Related]

  • 40. Targeting of epidermal Langerhans cells with antigenic proteins: attempts to harness their properties for immunotherapy.
    Flacher V, Sparber F, Tripp CH, Romani N, Stoitzner P.
    Cancer Immunol Immunother; 2009 Jul 12; 58(7):1137-47. PubMed ID: 18677477
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.